These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8508926)

  • 1. Amyloidogenicity of rodent and human beta A4 sequences.
    Dyrks T; Dyrks E; Masters CL; Beyreuther K
    FEBS Lett; 1993 Jun; 324(2):231-6. PubMed ID: 8508926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation.
    Dyrks T; Dyrks E; Hartmann T; Masters C; Beyreuther K
    J Biol Chem; 1992 Sep; 267(25):18210-7. PubMed ID: 1517249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid precursor protein truncated at any of the gamma-secretase sites is not cleaved to beta-amyloid.
    Paganetti PA; Lis M; Klafki HW; Staufenbiel M
    J Neurosci Res; 1996 Nov; 46(3):283-93. PubMed ID: 8933367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human and rodent Alzheimer beta-amyloid peptides acquire distinct conformations in membrane-mimicking solvents.
    Otvos L; Szendrei GI; Lee VM; Mantsch HH
    Eur J Biochem; 1993 Jan; 211(1-2):249-57. PubMed ID: 8425535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human and rodent sequence analogs of Alzheimer's amyloid beta A4 share similar properties and can be solubilized in buffers of pH 7.4.
    Hilbich C; Kisters-Woike B; Reed J; Masters CL; Beyreuther K
    Eur J Biochem; 1991 Oct; 201(1):61-9. PubMed ID: 1915378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid precursor protein secretion and beta A4 amyloid generation are not mutually exclusive.
    Dyrks T; Mönning U; Beyreuther K; Turner J
    FEBS Lett; 1994 Aug; 349(2):210-4. PubMed ID: 8050568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of beta A4 from the amyloid protein precursor and fragments thereof.
    Dyrks T; Dyrks E; Mönning U; Urmoneit B; Turner J; Beyreuther K
    FEBS Lett; 1993 Nov; 335(1):89-93. PubMed ID: 8243673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides.
    Hilbich C; Kisters-Woike B; Reed J; Masters CL; Beyreuther K
    J Mol Biol; 1992 Nov; 228(2):460-73. PubMed ID: 1453457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The amyloid peptide precursor in Alzheimer's disease.
    Octave JN
    Acta Neurol Belg; 1995 Dec; 95(4):197-209. PubMed ID: 8553793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4.
    Wood SJ; Wetzel R; Martin JD; Hurle MR
    Biochemistry; 1995 Jan; 34(3):724-30. PubMed ID: 7827029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane inserted APP fragments containing the beta A4 sequence of Alzheimer's disease do not aggregate.
    Dyrks T; Dyrks E; Masters C; Beyreuther K
    FEBS Lett; 1992 Aug; 309(1):20-4. PubMed ID: 1511741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of amino acid sequence on the fibrillogenicity and amyloidogenicity of the carboxy-terminus of beta-amyloid precursor protein.
    Caputo CB; Sobel IR; Sygowski LA; Lampe RA; Spreen RC
    Arch Biochem Biophys; 1993 Nov; 306(2):321-30. PubMed ID: 8215431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the involvement of histidine A(12) in the aggregation and precipitation of human relaxin induced by metal-catalyzed oxidation.
    Khossravi M; Shire SJ; Borchardt RT
    Biochemistry; 2000 May; 39(19):5876-85. PubMed ID: 10801339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candidate gamma-secretases in the generation of the carboxyl terminus of the Alzheimer's disease beta A4 amyloid: possible involvement of cathepsin D.
    Evin G; Cappai R; Li QX; Culvenor JG; Small DH; Beyreuther K; Masters CL
    Biochemistry; 1995 Oct; 34(43):14185-92. PubMed ID: 7578016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of structural variations in the carboxyl terminus of Alzheimer's disease-associated beta A4[1-42] amyloid using a monoclonal antibody.
    Jayasena UL; Gribble SK; McKenzie A; Beyreuther K; Masters CL; Underwood JR
    Clin Exp Immunol; 2001 May; 124(2):297-305. PubMed ID: 11422208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The beta A4 amyloid precursor protein binding to copper.
    Hesse L; Beher D; Masters CL; Multhaup G
    FEBS Lett; 1994 Jul; 349(1):109-16. PubMed ID: 7913895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the high affinity heparin binding site of the Alzheimer's disease beta A4 amyloid precursor protein (APP) and its enhancement by zinc(II).
    Multhaup G; Mechler H; Masters CL
    J Mol Recognit; 1995; 8(4):247-57. PubMed ID: 8588942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A beta A4 amyloid precursor protein gene and Alzheimer's disease.
    Hendriks L; Van Broeckhoven C
    Eur J Biochem; 1996 Apr; 237(1):6-15. PubMed ID: 8620894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homology of the amyloid beta protein precursor in monkey and human supports a primate model for beta amyloidosis in Alzheimer's disease.
    Podlisny MB; Tolan DR; Selkoe DJ
    Am J Pathol; 1991 Jun; 138(6):1423-35. PubMed ID: 1905108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of beta A4 production by specific modulation of beta-secretase activity.
    Urmoneit B; Reinsch C; Turner J; Czech C; Beyreuther K; Dyrks T
    J Mol Neurosci; 1995; 6(1):23-32. PubMed ID: 8562317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.